Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Almudena Zapatero

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
Practice patterns in the management of prostate cancer in Spain: results from a national survey among radiation oncologists in 2009Almudena Zapatero, José López-Torrecilla, Ismael Herruzo, et al.
Archivos Espanoles De Urologia|February 10, 2012
[Molecular markers as predictive factors biochemical failure after radical treatment of prostate cancer]Almudena Zapatero, Carmen Martín de Vidales, Alfonso Cruz Conde, et al.
Cancers|August 26, 2023
Node Oligorecurrence in Prostate Cancer: A ChallengeAlmudena Zapatero, Antonio José Conde Moreno, Marta Barrado Los Arcos, et al.
European Urology|May 20, 2008
Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us?Almudena Zapatero, Ricardo Mínguez, Santiago Nieto, et al.
Urologic Oncology|April 14, 2009
Updated results of bladder-sparing trimodality approach for invasive bladder cancerAlmudena Zapatero, Carmen Martin de Vidales, Ramón Arellano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR studyAlmudena Zapatero, Francisco Valcárcel, Felipe A Calvo, et al.
Hematology (Amsterdam, Netherlands)|August 13, 2002
Stage I-III Hodgkin's disease: outcome and pattern of failure following treatment with radiation therapy and chemotherapy in a modern eraAlmudena Zapatero, Mario A López, Laura Cerezo, et al.
Journal of Applied Clinical Medical Physics|January 11, 2012
Sensitivity of a helical diode array device to delivery errors in IMRT treatment and establishment of tolerance level for pretreatment QAFeliciano García-Vicente, Virginia Fernández, Rocío Bermúdez, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Long-term results after high-dose radiotherapy and adjuvant hormones in prostate cancer: how curable is high-risk disease?Almudena Zapatero, Feliciano García-Vicente, Carmen Martín de Vidales, et al.
Medical Physics|October 1, 2005
Statistical analysis of dose-volume and dose-wall histograms for rectal toxicity following 3D-CRT in prostate cancerFeliciano García-Vicente, Almudena Zapatero, Alejandro Floriano, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
Practice patterns in the management of prostate cancer in Spain: results from a national survey among radiation oncologists in 2009Almudena Zapatero, José López-Torrecilla, Ismael Herruzo, et al.
Archivos Espanoles De Urologia|February 10, 2012
[Molecular markers as predictive factors biochemical failure after radical treatment of prostate cancer]Almudena Zapatero, Carmen Martín de Vidales, Alfonso Cruz Conde, et al.
Cancers|August 26, 2023
Node Oligorecurrence in Prostate Cancer: A ChallengeAlmudena Zapatero, Antonio José Conde Moreno, Marta Barrado Los Arcos, et al.
European Urology|May 20, 2008
Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us?Almudena Zapatero, Ricardo Mínguez, Santiago Nieto, et al.
Urologic Oncology|April 14, 2009
Updated results of bladder-sparing trimodality approach for invasive bladder cancerAlmudena Zapatero, Carmen Martin de Vidales, Ramón Arellano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Risk-adapted androgen deprivation and escalated three-dimensional conformal radiotherapy for prostate cancer: Does radiation dose influence outcome of patients treated with adjuvant androgen deprivation? A GICOR studyAlmudena Zapatero, Francisco Valcárcel, Felipe A Calvo, et al.
Hematology (Amsterdam, Netherlands)|August 13, 2002
Stage I-III Hodgkin's disease: outcome and pattern of failure following treatment with radiation therapy and chemotherapy in a modern eraAlmudena Zapatero, Mario A López, Laura Cerezo, et al.
Journal of Applied Clinical Medical Physics|January 11, 2012
Sensitivity of a helical diode array device to delivery errors in IMRT treatment and establishment of tolerance level for pretreatment QAFeliciano García-Vicente, Virginia Fernández, Rocío Bermúdez, et al.
International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Long-term results after high-dose radiotherapy and adjuvant hormones in prostate cancer: how curable is high-risk disease?Almudena Zapatero, Feliciano García-Vicente, Carmen Martín de Vidales, et al.
Medical Physics|October 1, 2005
Statistical analysis of dose-volume and dose-wall histograms for rectal toxicity following 3D-CRT in prostate cancerFeliciano García-Vicente, Almudena Zapatero, Alejandro Floriano, et al.
Pageof 7